5,164 reports of this reaction
2.2% of all WARFARIN reports
#7 most reported adverse reaction
DIZZINESS is the #7 most commonly reported adverse reaction for WARFARIN, manufactured by Amneal Pharmaceuticals LLC. There are 5,164 FDA adverse event reports linking WARFARIN to DIZZINESS. This represents approximately 2.2% of all 237,331 adverse event reports for this drug.
WARFARIN has an overall safety score of 92 out of 100. Patients taking WARFARIN who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for WARFARIN, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for WARFARIN:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 5,164 FDA reports for WARFARIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 2.2% of all adverse event reports for WARFARIN, making it a notable side effect.
If you experience dizziness while taking WARFARIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.